Welcome to LookChem.com Sign In|Join Free

CAS

  • or

133083-29-1

Post Buying Request

133083-29-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

133083-29-1 Usage

Chemical compound

2-amino-3-(7-methoxy-4-coumaryl)propionic acid

Structure

Consists of an amino group, a propionic acid chain, and a 7-methoxy-4-coumaryl group

Derivative of

Coumarin

Properties

Anticoagulant, anti-inflammatory

Pharmaceutical applications

Anti-inflammatory, anticoagulant

Additional effects

Potential antioxidant effects

Potential uses

Treatment and prevention of blood clots, cardiovascular diseases, inflammation-related disorders

Further research

Development of new medications for various health conditions

Check Digit Verification of cas no

The CAS Registry Mumber 133083-29-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,3,0,8 and 3 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 133083-29:
(8*1)+(7*3)+(6*3)+(5*0)+(4*8)+(3*3)+(2*2)+(1*9)=101
101 % 10 = 1
So 133083-29-1 is a valid CAS Registry Number.
InChI:InChI=1/C13H13NO5/c1-18-8-2-3-9-7(4-10(14)13(16)17)5-12(15)19-11(9)6-8/h2-3,5-6,10H,4,14H2,1H3,(H,16,17)

133083-29-1Relevant articles and documents

Development of the first internally-quenched fluorescent substrates of human cathepsin C: The application in the enzyme detection in biological samples

??gowska, Monika,Hamon, Yveline,Wojtysiak, Anna,Grzywa, Renata,Sieńczyk, Marcin,Burster, Timo,Korkmaz, Brice,Lesner, Adam

, p. 91 - 102 (2016)

Cathepsin C is a widely expressed cysteine exopeptidase that is mostly recognized for the activation of the granule-associated proinflammatory serine proteases in neutrophils, cytotoxic T lymphocytes and mast cells. It has been shown that the enzyme can be secreted extracellularly; however, its occurrence in human bodily fluids/physiological samples has not been thoroughly studied. In the course of this study, the first fluorescence resonance energy transfer peptides for the measurement of the activity of human cathepsin C were designed and synthesized. Two series of tetra- and pentapeptide substrates enabled the detailed S′ specificity study of cathepsin C, which has been examined for the first time. The extensive enzymatic studies of the obtained compounds resulted in the selection of the highly specific and selective substrate Thi-Ala(Mca)-Ser-Gly-Tyr(3-NO2)-NH2, which was successfully employed for the detection of cathepsin C activity in complex biological samples such as cell lysates, urine and bronchoalveolar lavage fluids. Molecular docking of the selected substrate was performed in order to better understand the binding mode of the substrates in the active site of cathepsin C.

Methods of modifying N-termini of a peptide or protein using transferases

-

Page/Page column 21, (2016/08/03)

The invention includes a selective method of modifying the N-terminus of a protein using an aminoacyl tRNA transferase. In certain embodiments, the method comprises contacting a solution of the protein or peptide with a transferase and a derivative of a molecule, whereby the N-terminus of the protein or peptide is derivatized with the molecule.

N-terminal protein modification using simple aminoacyl transferase substrates

Wagner, Anne M.,Fegley, Mark W.,Warner, John B.,Grindley, Christina L. J.,Marotta, Nicholas P.,Petersson, E. James

supporting information; experimental part, p. 15139 - 15147 (2011/11/06)

Methods for synthetically manipulating protein structure enable greater flexibility in the study of protein function. Previous characterization of the Escherichia coli aminoacyl tRNA transferase (AaT) has shown that it can modify the N-terminus of a protein with an amino acid from a tRNA or a synthetic oligonucleotide donor. Here, we demonstrate that AaT can efficiently use a minimal adenosine substrate, which can be synthesized in one to two steps from readily available starting materials. We have characterized the enzymatic activity of AaT with aminoacyl adenosyl donors and found that reaction products do not inhibit AaT. The use of adenosyl donors removes the substrate limitations imposed by the use of synthetases for tRNA charging and avoids the complex synthesis of an oligonucleotide donor. Thus, our AaT donors increase the potential substrate scope and reaction scale for N-terminal protein modification under conditions that maintain folding.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 133083-29-1